Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.57 |
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22030229 | 1.00 | GLP1R (0.57) | GLP1RNOD1TSHRRECQL | |
| SCHEMBL24652598 | 0.92 | GLP1R (0.48) | GLP1RNOD1 | |
| SCHEMBL22026448 | 0.90 | GLP1R (0.46) | GLP1RNOD1 | |
| SCHEMBL19135682 | 0.90 | GLP1R (0.51) | GLP1RNOD1 | |
| SCHEMBL20706160 | 0.88 | GLP1R (0.49) | GLP1RNOD1TSHRRECQL | |
| SCHEMBL14683457 | 0.87 | GLP1R (0.44) | GLP1RNOD1 | |
| SCHEMBL19599343 | 0.87 | GLP1R (0.44) | GLP1RNOD1 | |
| SCHEMBL21316645 | 0.87 | GLP1R (0.50) | GLP1RNOD1 | |
| SCHEMBL24198552 | 0.87 | GLP1R (0.49) | GLP1RNOD1 | |
| SCHEMBL24788148 | 0.86 | GLP1R (0.50) | GLP1RNOD1TSHRRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200165313-A1 | EGF(A) ANALOGUES, PREPARATION, FORMULATIONS AND USES THEREOF | NOVO NORDISK A/S (DK) | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200165313-A1 | EGF(A) ANALOGUES, PREPARATION, FORMULATIONS AND USES THEREOF | EGFR, VEGFA, ERBB2 | GLP1R 30/4885NOD1 4450/4885TSHR 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.